分类：
胆道癌
6-5-2024
Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy‐Refractory Biliary Tract Cancer: A Multicenter Open‐Label Phase 1/2a Trial
NK细胞
,
临床文献
,
免疫细胞
,
肿瘤
,
胆道癌